|
|
Volumn 35, Issue 12, 2010, Pages 1045-1067
|
|
Highlights from the 50th interscience conference on antimicrobial agents and chemotherapy (ICAAC)
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACHN 490;
AIC 246;
AN 3365;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIMALARIAL AGENT;
ANTIVIRUS AGENT;
BC 3781;
CB 182804;
CB 183315;
CEFTAZIDIME;
CHEMOKINE RECEPTOR CCR2 ANTAGONIST;
CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER;
COBICISTAT;
CXA 101;
CYTOMEGALOVIRUS VACCINE;
EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
EP 017796;
FESTINAVIR;
FOSDEVIRINE;
GSK 1322322;
GSK 1349572;
IMMUNOLOGICAL ADJUVANT;
INFLUENZA VACCINE;
INTEGRASE INHIBITOR;
LDI 028;
LDK 733;
LMV 601;
LT 00786;
MK 3118;
MK 7655;
MOXIFLOXACIN;
NB 003;
NB 1008;
NIBR 6465;
NP 339;
NZ 17074;
OBP 601;
OMEPRAZOLE;
PIPERACILLIN PLUS TAZOBACTAM;
PLEUROMUTILIN;
PNU 100480;
PP 9706642;
RALTEGRAVIR;
RX 101005;
RX 101079;
RX 101127;
TAZOBACTAM;
TP 271;
TP 434;
TRANSVAX;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ANTIFUNGAL ACTIVITY;
ANTIMALARIAL ACTIVITY;
ANTIMICROBIAL ACTIVITY;
COMMUNITY ACQUIRED PNEUMONIA;
CONFERENCE PAPER;
CYTOMEGALOVIRUS INFECTION;
DNA VIRUS INFECTION;
DRUG DOSE INCREASE;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DYSPEPSIA;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IN VITRO STUDY;
NAUSEA;
NEPHROTOXICITY;
NONHUMAN;
SINGLE DRUG DOSE;
SKIN INFECTION;
UNSPECIFIED SIDE EFFECT;
URINARY TRACT INFECTION;
VACCINATION;
|
|
EID: 79956191527
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.2010.035.012.1583180 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (147)
|
